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INTRODUCTION 
The polyposis syndromes, a heterogeneous group of 
diseases, have been a major focus of study for the last decade and 
provide critical insight into the molecular pathogenesis of cancel'. 
Despite intense study, these important syndromes are still 
clinically confusing and proper objective identification is 
necessary for appropriate clinical management (Sweet et al., 
2005). 
The term "polyp" derives from the Greek for "multiple feet" 
or "little nipple". In current clinical practice a polyp is defined as 
any nodule or mass that projects above the level of the 
surrounding mucosa, as in the gut, to form a macroscopically    
visible structure (Najib et al., 2002; Vinay t'/ al., 2007). Traction 
on the mass may create a stalked, or  pedunculated, polyp. 
Alternatively, the polyp may be sessile, without a definable stalk. 
The polyps that are formed as a result   of abnormal mucosal 
maturation, inflammation, or architecture, are non-neoplastic and 
do not have malignant potential, but those that arise as the result 
of epithelial proliferation and dysplasia are termed adenomatous   
polyps   or   adenomas.    They   are   true neoplastic lesions and 
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are precursors of carcinoma. Some polypoid lesions may be 
caused by submucosal or mural tumors. However, as with the 
stomach, the term polyp, unless otherwise specified, refers to 
lesions arising from the epithelium of the mucosa (Vinay et al., 
2007). 
 Gastrointestinal polyps are being identified more frequently 
today because of increased awareness, screening and improved 
diagnostic tools. The entire gastrointestinal tract is at risk for 
polyp development but the adult colon and rectum account for the 
majority of polyps. Painless, bright red, rectal bleeding with 
normal stool frequency and consistency is the hallmark 
presentation of colorectal polyps at any age (Vinay et al, 2007; 
Attard and Young, 2006). 
Gastric polyps are uncommon and are most frequently 
hyperplastic polyps, fundic gland polyps and adenomatous polyps. 
Hyperplastic and fundic gland polyps are essentially innocuous. In 
contrast, there is a definite risk of an adenomatous polyp 
harboring adenocarcinoma, which increases with polyp size 
(Vinayc/a/., 2007). 
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The classification of intestinal tumors is the same for the 
small and large bowel. Hyperplastic polyps are the most common 
polyps of the colon and rectum. When single, they do not have 
malignant potential. However a lesion known as sessile serrated 
adenoma, which has some similarities with hypeiplastic polyps, 
may have malignant potential (Vinay et al, 2007; Jass, 2003; 
Bariol et al., 2003; Snover et al., 2005, Torlakovic etal, 2003). 
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AIMS AND OBJECTIVES 
To study the incidence and prevalence of gastrointestinal 
polyps with a clinical, endoscopic and histopathologic correlation. 
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REVIEW OF LITERATURE 
Colorectal cancer is one of the most common neoplasms of 
industrialized nations, and accounts for approximately 9% of all 
cancer [1]. It is the second leading cause of cancer-related death in 
the Western world [2]. 
Most colorectal cancer develops from adenomas, the 
precursor lesions [2–5]. Adenomas are benignneoplasms with 
malignant potential; they may harbor an invasive carcinoma. 
Adenomas occur sporadically or as part of a polyposis syndrome. 
Hereditary polyposes account for approximately 1% of all 
colorectal carcinomas; hereditary non-polyposis colorectal cancer 
(HNPCC) accounts for approximately another 5%, and perhaps 
30% or more of sporadic carcinomas may be inherited [6]. In 
addition to its clinical relevance as a precancerous lesion, the 
adenoma provides a model of early neoplastic change that has 
contributed to our understanding of the mechanisms of colorectal 
carcinogenesis [7]. Colorectal cancer is highly curable if 
diagnosed in the early stages [8], and malignant polyps constitute 
the precursors of early colorectal cancer. The pathologist plays a 
critical role in the management of the patient with endoscopically 
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removed polyps, especially malignant polyps, because the 
histopathological interpretation is the most important 
consideration for subsequent management [9]. 
ADENOMAS 
Adenoma is a benign intraepithelial neoplasm composed of 
dysplastic cells. Most colorectal adenomas are present as 
protuberant masses or polyps. They must be differentiated from 
other types of epithelial polyps. They are classified according to 
the pathological process that is believed to underlie their origin 
[7]. Adenomas, the benign glandular neoplasms that precede colon 
cancer development, originate from the intestinal epithelium. They 
occur singly or in multiples. When multiple, the patients may have 
a genetic syndrome. 
BIOLOGICAL ALTERATIONS IN ADENOMAS 
Despite their differing structure, there are two common 
features in adenomas: a dysregulated proliferation and the failure 
to fully differentiate the epithelium. The dysregulated 
proliferation is evidenced by an upward shift in the proliferative 
compartment. Mitotic figures, including abnormal ones, are 
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present throughout the entire length of the hyperchromatic, 
adenomatous epithelium. 
In the normal colon most apoptosis occurs near the luminal 
surface. Adenomas contain numerous apoptotic cells which often 
lie at the adenomatous base, a reversal of the normal distribution. 
This suggests that adenomas exhibit a reversed epithelial cell 
migration and have an inward growth pattern directed toward the 
crypt base rather than toward the lumen [10]. 
Adenomas also tend to show abnormalities in epithelial cell 
differentiation: adenomatous epithelium resembles the replicating 
cells normally present in the crypt base. Tall cells with prominent, 
elongated, hyperchromatic nuclei produce a characteristic “picket 
fence” pattern as they line the adenomatous glands. The 
adenomatous epithelium contains incompletely differentiated 
goblet cells and absorptive cells at all levels of the crypt, 
including the free surface. Adenomatous glands show no evidence 
of differentiation toward the luminal surface. 
ADENOMA GROWTH 
Small adenomas represent neoplastic clonal populations of 
colonic epithelial cells, suggesting that they arise from a single 
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abnormal precursor stem cell. Adenomas begin in a single crypt, 
and then grow by replacing normal epithelium in a centrifugal 
manner. Unicryptal adenomas are rare and most typically affect 
patients with adenomatous polyposis syndrome. 
The neoplastic cells appear to cluster at the luminal aspect 
of the mucosa without extending to the base of the glands. 
Normal-appearing mucosa lies below the adenomatous glands. In 
86% of early tubular adenomas, the number of glands opening 
along the polyp surface is larger than the number of gland bases; 
this difference increases with polyp size [11]. Gland proliferation 
is predominant in the upper crypts and along the surface of the 
lesions. 
Early adenomas are present as small growths with a very 
benign tubular histology. The progression of most small adenomas 
is slow, and occurs over several years.  
On average, small adenomas double their diameter in 10 
years [12]. Some adenomas ultimately progress to invasive 
cancers, but not all adenomas progress; some may stay stable and 
may even regress or disappear while new ones may form [13]. 
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INCIDENCE 
Adenomas are the most commonly biopsied tumors of the 
large bowel [14]. Incidence rates of adenomas vary considerably 
throughout the world. Geographic areas exhibiting a high risk for 
colon cancer also exhibit a high risk for adenoma development, 
and vice versa. The incidence in the general population varies 
from 0% to 69%, depending on the country of origin [15,16] and 
on how the adenomas are detected [17]. In Western populations, 
the average prevalence rate for adenomas from flexible 
sigmoidoscopy screening is 10%, and colonoscopic screening 
prevalence averages 25% [18]. Adenomas accounted for 68% of 
all polyps removed by colonoscopy in the National Polyp Study 
[19]. 
In the 50- to 59-year age group, population screening studies 
and autopsy studies show an adenoma prevalence rate of 41.3% to 
69% [20], increasing in advancing years up to 88% in centenarians 
[21]. Arminski and McLean [22] documented a 7.5% increase in 
adenoma incidence per decade.  
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Adenoma incidence peaks at age 60 to 70 years; it also 
occurs more frequently in men (61.6%) than in women (38.4%) 
[19]. 
Based on endoscopic studies, most sporadic adenomas arise 
in the rectosigmoid colon (66% to 77%) [23]. Adenomas also 
occur from a distal to a proximal location as patients age [15–
17,24]; thus, left-sided adenomas are found more commonly in 
younger age groups, and right-sided lesions increase in frequency 
in individuals older than 65 years of age. Some adenomas tend to 
cluster. This means that multiple adenomas tend to occur closer 
together than would normally be expected from the general 
distribution of adenomas. This phenomenon occurs in all colonic 
segments, but is less pronounced in the rectum than in other parts 
of the large intestine [25]. 
MULTIPLE POLYPS 
Individuals with one adenoma have a 40% to 55% likelihood 
of having additional synchronous lesions [23,26,27]. The 
additional adenomas can be detected at the same time as the initial 
adenoma (synchronous adenomas), or at a different time 
(metachronous adenomas). The prevalence of multiple adenomas 
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increases with age (about 9% of those under 60 years, and 28% of 
people older than 75 years have three or more adenomas). The 
incidence of large intestinal adenomas occurring synchronously 
with carcinomas is approximately double that of adenomas 
occurring alone. 
A relationship exists between adenoma multiplicity and 
histological findings. In patients with a single adenoma, 38.8% are 
villous, whereas those with multiple adenomas have a 60.1% 
chance of having at least one villous adenoma [28]. Patients with 
multiple adenomas are also more likely to harbor at least one 
adenoma that contains high-grade dysplasia (13.8%) versus 
patients with a single adenoma (7.3%). 
The overall recurrence rates for new adenomas are estimated 
from 20% up to 60%, with average followup times of 3 to 10 years 
after index polypectomy [17,23,29]. Most recurrences occur in the 
first two years following polypectomy. The estimated time of 
finding new adenomas is 58 months for patients clear on the first 
colonoscopy, and 16 months for patients who had adenomas on the 
first examination [30,31]. 
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Villous tumors, particularly broadly sessile ones, usually 
have less well-defined borders than tubular adenomas, and 
therefore have a greater tendency to recur after local resection 
than smaller, pedunculated adenomas. 
Endoscopic follow-up studies to evaluate new adenomas are 
hampered by the fact that as many as 25% to 27% of adenomas 
measuring less than 5 mm in diameter, and up to 6% of adenomas 
measuring 1 cm in diameter are missed during a single endoscopic 
examination [32,33]. Right-sided adenomas are missed more often 
(27%) than left-sided adenomas (21%) [32]. Relatives of 
individuals with colorectal cancer have an adenoma prevalence 
rate of 39%. 
CLINICAL FEATURES 
Bleeding is the most frequent symptom reported, and occurs 
more often in left-sided lesions than rightsided adenomas [34]. 
Small adenomas, ranging up to 1 cm in maximum diameter, 
usually remain asymptomatic unless they are traumatized by the 
passage of well-formed, hardened stool. Larger lesions become 
symptomatic, with the symptoms depending on polyp size and 
location. The bleeding is seldom severe. The incidence of bleeding 
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increases with increasing adenoma size and once a carcinoma 
develops within the adenoma. Villous tumors are more likely to 
bleed than tubular ones, since they tend to be larger [35]. Cecal 
lesions that block the appendiceal orifice may produce symptoms 
mimicking acute appendicitis. 
GROSS FEATURES 
Grossly, adenomas assume one of three major growth 
patterns: (a) pedunculated, (b) sessile, or (c) flat or depressed. 
Most sporadic colorectal adenomas appear as exophytic [8]. The 
categorization of adenomas according to their macroscopic 
appearance is important, as it may influence surgical treatment. 
PEDUNCULATED ADENOMAS 
Pedunculated adenomas appear as exophytic, mucosal 
protrusions with a lobulated head and a stalk covered by normal 
mucosa. In pedunculated polyps, the adenomatous epithelium 
remains confined to the mucosa of the head of the polyp. The stalk 
consists of normal mucosa, including the muscularis mucosae and 
submucosal tissue, in continuity with the major part of the bowel 
wall. 
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Pedunculated polyp with the typical lobulated head and a 
stalk covered by normal mucosa 
SESSILE ADENOMAS 
Sessile adenomas attach to the mucosa by a broad base (Fig. 
2.2). Sessile adenomas are often less well circumscribed than 
pedunculated ones. Because of their ill-defined edges, they are 
difficult to delineate, and have a greater tendency to recur 
following local excision. 
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Sessile polyp attached to the mucosa by a broad base. On 
the right is a colonic tattoo: a collection of black non-
degradable pigments in the submucosa 
FLAT (DEPRESSED) ADENOMAS 
The terms superficial, flat, and depressed non-polypoid 
adenoma are used synonymously to describe this entity [8], but 
have two different macroscopic aspects. 
The overall prevalence of non-polypoid colorectal 
neoplasms is variable, and it accounts for from about 35% [36] to 
42% of adenomas [37]. Flat adenomas are lesions that lack an 
exophytic polypoid configuration. They consist of slightly 
elevated dysplastic mucosal plaques that are never greater than 
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twice the thickness of the surrounding normal colonic mucosa [38] 
(Fig. 2.3). They constitute a special subgroup of adenomas with a 
greater potential for malignant transformation, while still being 
smaller than exophytic adenomas [8]. Depressed adenomas have a 
collarette of epithelium similar to that seen in a flat adenoma, but 
with a depression that is usually central. Because flat or depressed 
adenomas display little or no mucosal elevation,they can be very 
difficult to see endoscopically and pathologically, especially in the 
proximal colon [39]. They are often more clearly delineated 
endoscopically after spraying the mucosa with methylene blue or 
indigo carmine [40–43]. The failure to recognize these flat lesions 
may account for the lingering concept of de novo colorectal 
carcinoma [44]. Depressed adenomas tend to arise more 
commonly in the right colon than elsewhere [44]. They occur in 
HNPCC syndrome, sporadically, or in patients with familial 
adenomatous polyposis (FAP) [45]. The frequency of flat adenoma 
is 50.7% in HNPCC patients. Generally, adenomas appear as 
grossly homogeneous, soft lesions without induration, ulceration, 
or fixation. Areas of ulceration, depression, or firmness suggest 
the possibility of a coexisting carcinoma. 
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Flat adenoma: low-power photomicrograph demonstrating a flat 
adenoma with approximately the same thickness of non-
neoplastic colonic mucosa and containing crowded glands lined 
by hyperchromatic and mucin-depleted epithelium concentrated 
at the surface. In the biopsy on the right there are non-neoplastic 
glands on each side of the dysplastic epithelium 
HISTOLOGICAL FEATURES 
There are four categories of adenoma: tubular, villous, 
tubulo-villous and flat-depressed [8]. The factors controlling the 
growth pattern of adenomas are unknown [7]. 
TUBULAR ADENOMA 
Tubular adenomas maintain the original crypt architecture, 
but adenomatous epithelium replaces the normal colonic 
epithelium in lining the crypts (Fig. 2.4). This is the most common 
type of adenoma (about 68% to 87%) [19,46,47]. Tubular lesions 
are those that contain greater than 80% of a tubular component. 
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Tubular adenomas consist of closely packed branching tubules 
separated by varying amounts of lamina propria. The tubule may 
be relatively regular, or when the adenomatous tubules grow, they 
may branch and show considerable irregularity. Small tubular 
adenomas usually have a dysplastic surface epithelium overlying 
normal epithelium in the crypt base. 
VILLOUS ADENOMA 
Villous adenomas (approximately 20%) have villi with cores of 
lamina propria covered by a single layer of adenomatous epithelium. 
Villous lesions are those that contain greater than 80% of a villous 
component [46] (Fig. 2.5). Villous adenomas fall into three types: (a) 
flat, carpet-like masses; (b) lobulated, bulky, sessile masses; (c) 
pedunculated lesions with short, broad pedicles. 
 
Villous adenoma characterized by long finger-like fronds 
lined by neoplastic epithelium 
19 
 
Tubulo-villous adenoma: mixture of tubular and villous 
architecture – villous fronds and tubular glands 
TUBULO-VILLOUS ADENOMA 
Tubulo-villous adenomas contain a mixture of both tubular 
and villous patterns, or have broad villi containing short tubular 
structures. Tubulo-villous lesions are those that contain from 20% 
to 79% villous components [46]. They tend to be larger than 
tubular adenomas, with a mean diameter of 19 mm [22] (Fig. 2.6). 
A villous component is present in 35% to 75% of all adenomas 
measuring more than 1 cm in largest diameter [48]. 
FLAT-DEPRESSED ADENOMA 
Flat or depressed adenomas are a variant of tubular adenoma 
with little or no mucosal elevation. The thickness of the 
adenomatous mucosa does not exceed twice than that of the 
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normal mucosa [8], and the adenomatous changes concentrate near 
the luminal surface. Flat adenomas have a high incidence of 
highgrade dysplasia [38,45], and they are more likely to harbor 
invasive carcinoma than is typically seen in polypoid counterparts 
[49]. There is a high association with synchronous and 
metachronous invasive colorectal carcinomas [8]. Depressed 
adenomas measuring less than 1 mm in diameter show horizontal 
growth between the normal adjacent crypts, often leaving normal 
crypts entrapped as residual islands. 
DIAGNOSIS 
The histological features of adenomas may be defined as 
low- or high-grade dysplasia. 2.10.1 Low-Grade Dysplasia Low-
grade dysplasia consists of stratified dysplastic epithelium that 
retains its columnar shape. The nuclei are spindle or oval shaped. 
The stratified nuclei tend to remain in the basal epithelium, 
extending no more than three-quarters of the height of the 
epithelium. Minor cytological variations including numerous 
mitoses, mild nuclear pleomorphisms, and variations in cell size 
and shape may occur in adenomatous epithelium; however, these 
features (more common in larger polyps) are insufficient for a 
diagnosis of high-grade dysplasia. 
21 
 
 
Low-grade dysplasia; a, small tubular adenomatous gland 
with very little atypia; normal colonic glands on the right; 
b, small tubular adenomatous gland with moderate atypia 
Sometimes it is difficult distinguish a small tubular adenoma 
from reactive epithelium present in an inflamed mucosa, because 
reactive glands appear more basophilic than normal and the nuclei 
may exhibit pseudostratification. In these cases it is useful 
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examine the degree of differentiation of the epithelium along the 
length of the tubular crypt. If the entire gland is not replaced by 
basophilic epithelium, then its restriction to the bottom portion of 
the crypt serves to identify the epithelium as regenerative. 
Conversely, in small adenomas, the adenomatous glands appear 
more basophilic at the surface of the lesion, and nonneoplastic 
epithelium lies below it [8]. 
HIGH-GRADE DYSPLASIA 
High-grade dysplasia is characterized by the presence of 
marked cytological atypia, the loss of cellular polarity, 
stratification of cells to the luminal surface of the glands, and 
crowding with occasional formation of solid nests of dysplastic 
cells. The cells show loss of columnar shape with cellular 
rounding and an increase of nuclear-to-cytoplasmic ratios. Cells 
remain confined within the basement membrane of the original 
colonic crypt, or they may extend into the surrounding lamina 
propria, with a cribriform pattern obliterating the intervening 
stroma. Glandular density increases. (Fig. 2.8b) The presence of 
high-grade dysplasia strongly correlates with a contiguous 
invasive carcinoma. 
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High-grade dysplasia represents the extreme end of the 
spectrum of abnormal histological changes, short of invasive 
carcinoma in the adenoma–carcinoma continuum. Individual 
adenomas may contain transitions between high-grade and low-
grade dysplasia. The percentage of adenomas containing high-
grade dysplasia increases significantly with increasing adenoma 
size, villous architecture, multiplicity of adenomas, and age 
greater than 60 years [50,51]. High-grade dysplasia encompasses 
the histological changes called carcinoma in situ [9] and 
intramucosal carcinoma (Fig. 2.8a). The latter is when there is 
extension of the neoplastic cells through the basement membrane 
of the crypt into the surrounding lamina propria but not beyond 
[52,53]; intramucosal carcinoma includes that which involves the 
muscularis mucosae. Neoplastic glands in and among a splayed 
muscularis mucosae is not invasive cancer. Only when cancer 
invades into the submucosa does it have the potential to 
metastasize [8,9,52]. 
Neither carcinoma in situ nor intramucosal carcinoma have a 
clinically significant potential for metastasis (if all neoplastic 
tissue is removed), and the lesions do not require additional 
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treatment [8]. Hence this term should only be used in conjunction 
with the comment that intramucosal adenocarcinoma lacks the 
potential for metastases, and if totally removed it has been 
adequately treated [9].  
The pathology report should state the macroscopic 
description (pedunculated or sessile polyp, and the greatest 
dimension), the highest degree of dysplasia present in the 
adenoma, whether or not it has villous features, the completeness 
of its removal, and the presence or absence of invasive tumor [54]. 
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High-grade dysplasia; a, characterized by cellular 
disorganization and more marked cytologic atypia, the 
degree of nuclear pleomorphism is sufficient to call it 
intramucosal carcinoma; b, stratification of cells to the 
luminal surface of the glands, a feature of high-grade 
dysplasia 
REPORTING COLORECTAL ADENOMA 
Gross features 
• Macroscopic growth pattern: pedunculated/sessile/ flat polyp. 
• Greatest dimension. 
Histological features 
• Architecture: tubular/villous/tubulo-villous. 
• Grade: low-grade/high-grade dysplasia. 
• Status of the resection margin. 
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ADENOMA–CARCINOMA SEQUENCE 
Adenoma constitutes the precursor lesion for most colorectal 
carcinomas [2–5]. Two concepts can explain the understanding 
that now exists in relation to the evolution of colorectal neoplasia. 
The first is the model provided by the adenoma–carcinoma 
concept and is supported by clinical, pathological, and 
epidemiological data collated over several decades [3]. The second 
model is related to the hereditary bowel cancer syndromes (FAP 
and HNPCC) that led to the discovery of important cancer genes 
[55,56]. 
The earliest lesions consist of pseudostratified, immature, 
mildly dysplastic, adenomatous cells. In some cases, one may see 
a continuous histological spectrum of increasing degrees of 
dysplasia culminating in the development of an invasive 
carcinoma [8]. 
There are publications purporting “de novo” carcinomas that 
are open to various interpretations. It should be recalled that 
adenomas may, on rare occasions, be flat or even depressed, 
presenting essentially as dysplasia within flat mucosa [40,57]. “De 
novo” carcinoma may represent an early cancer that has destroyed 
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a small adenoma [58]. Nevertheless, some studies support the 
view that the “de novo” cancer and classical cancer represent 
divergent evolutionary pathways. “De novo” carcinoma shows a 
non-polypoid, superficially spreading, growth pattern, and a more 
aggressive course [7]. 
Morphological features that determine the malignant 
potential of an adenoma are size, growth pattern, and grade of 
dysplasia [7]. Carcinomas are more likely to arise in larger 
adenomas than smaller ones. The incidence of carcinoma in an 
adenoma increases as the size of the adenoma increases. The 
prevalence of cancer in adenomas under 1 cm is only about 1%, in 
those between 1 and 2 cm in diameter it is about 10%, and in those 
over 2 cm there is nearly a 50% malignancy rate. 
Adenomas with a villous pattern have a higher malignant 
potential than those with a tubular pattern. 
The malignancy rate for tubular adenomas is about 5%, but 
rises to 40% in villous ones. In tubulo-villous types, the 
malignancy rate is about 22%. Although histological type is very 
important in the assessment of malignant potential, it seems that 
size is the paramount feature [59]. 
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The malignant potential of an adenoma increases as grading 
of dysplasia increases, irrespective of histological growth pattern. 
Both growth pattern and dysplasia grade correlate with 
adenomatous size. Usually, small adenomas (those under 1 cm) 
show low-grade dysplasia and have very low malignant potential. 
The risk of cancer developing in such adenomas is only 5% after 
15 years. The malignancy rate rises to 27% if a high-grade 
dysplasia is present; however, it is rare in a polyp of this size. A 
similar relationship is seen in adenomas that are 1 to 2 cm in 
diameter in relation to the grade of dysplasia. In adenomas over 2 
cm in size, the malignancy rate is high but bears little relation to 
the degree of dysplasia. 
Although the trend observed for size and malignant change 
is considerably greater than the trend for dysplasia and 
malignancy, there are reasons to suspect that at the biological 
level of dysplasia is the most selective marker of increased 
malignant potential [7]. Even though adenomas clearly constitute 
the precursor lesion for most carcinomas, a vast gap exists in the 
prevalence rates of adenomas and carcinomas, indicating that 
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some 90% to 95% of adenomas will never become malignant 
during a person’s lifetime [16]. 
This fact offers the challenge of developing markers for the 
identification of those adenomas that have a high probability of 
progressing to an invasive carcinoma.  
Actuarial analysis reveals a cumulative risk of developing 
cancer in adenomas that are not removed at 5, 10, and 20 years of 
2.5%, 8%, and 24%, respectively. It is estimated that the 
conversion rate of adenomas to cancer is 0.25% per year [60]. 
ADENOMAS CONTAINING CARCINOMA (MALIGNANT 
POLYPS) 
A malignant polyp is an adenoma containing invasive 
carcinoma. The diagnosis of invasive carcinoma is made when 
neoplastic glands have invaded and penetrated through the 
muscularis mucosae into the submucosa of the bowel wall or into 
the submucosa of the stalk of an adenoma [9,61]. Invasio into, but 
not through, the muscularis mucosae is still “intramucosal 
carcinoma”. Desmoplasia often surrounds the invading glands, 
which have irregular, angled contours and show cytological 
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features of malignancy [8]. This feature must be differentiated 
from “entrapped” (pseudoinvasive) mucosa. 
Submucosal invasion is most easily recognized by the 
intermingling of the malignant glands with normal submucosal 
structures including medium-sized blood vessels, fat, nerves, 
ganglia, and large lymphatics [8]. Various degrees of substitution 
of an adenoma by carcinoma may occur. A polypoid carcinoma is 
a polyp consisting entirely of cancer with no remaining benign 
adenoma. 
Malignant adenomas represent an early form of colorectal 
carcinoma. Approximately 42 to 85% of early colorectal cancers 
are pedunculated, and 15–58% are sessile [62,63]. Carcinomas 
arising from pedunculated adenomas cause the biggest clinical 
questions with regard to further management. Various opinions 
exist for managing patients after endoscopic removal of malignant 
polyps. Some of these lesions require further therapy, others do 
not.  
One possibility is that all patients with malignant polyps 
should undergo standard resection [64]; another opinion is that a 
conservative approach should be maintained in the absence of 
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cancer at the resection line [65]. The present mainstream opinion, 
however, is that all malignant polyps removed by endoscopic 
polypectomy require evaluation of histological parameters that 
have been demonstrated to be significant prognostic factors 
related to the risk of adverse outcome (i.e. lymph node metastases 
or local recurrence from residual malignancy) after polypectomy 
[54,65–69]. The management of these malignant adenomas 
depends upon their histological risk factors and the patient’s 
general condition [70]. 
The dilemma about managing patients after endoscopic 
removal of malignant polyps is best resolved by a 
multidisciplinary team involving the surgeon, pathologist, and 
endoscopist, and taking the patient’s condition and wishes into 
account [70]. The clinician faces the therapeutic decision as to 
whether or not polypectomy alone is adequate therapy or whether 
the patient requires a definitive surgical resection; therefore, the 
metastatic risk must be determined to plan future therapy. 
After endoscopic polypectomy, all the histological risk 
factors need to be simultaneously and carefully evaluated by the 
pathologist to identify and classify patients into low-risk or a 
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high-risk group associated with an adverse outcome (i.e. lymph 
node metastasis or local recurrence from residual malignancy) 
[68,71]. 
PROGNOSTIC FACTORS OF METASTATIC 
Risk or Residual Disease Present in Malignant Adenomas 
Histological parameters have been developed over the years to 
identify prognostic factors of metastatic risk and reduce the 
number of unnecessary additional laparotomies, while selecting 
which adenomas have very little or virtually no risk of nodal 
metastasis and/or local recurrence [68]. 
The pathological features that have independent prognostic 
significance and that are crucial for evaluating risk of adverse 
outcome (e.g. increased risk of residual disease or lymph node 
metastases) include histological grade, completeness of resection 
margin, lymphatic-venous vessel involvement, tumor budding, and 
level of invasion of the submucosa. 
GRADE OF DIFFERENTIATION 
The grading system is based on gland or tubule formation 
and the cytological features of adenocarcinoma (how closely it 
approximates normal epithelium) [9]. The neoplastic components 
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should be divided into well-differentiated (grade 1 – G1), 
moderately differentiated (grade 2 – G2), poorly differentiated 
adenocarcinoma (grade 3 – G3), and undifferentiated carcinomas 
(grade 4 – G4). The World Health Organization (WHO) classifies 
the neoplastic components into just two categories: low-grade (G1 
and G2) and high-grade (G3 and G4) adenocarcinomas [61]. Well-
differentiated (G1) adenocarcinoma exhibits glandular structures 
in more than 95% of the tumor. Moderately differentiated (G2) 
adenocarcinoma has 50 to 95% glandular structure. Poorly 
differentiated (G3) adenocarcinoma has 5 to 50% glandular 
structure. Undifferentiated (G4) carcinoma has less than 5% 
glandular structure [61]. In order to reduce the degree of inter-
observer variability in the grading of adenocarcinoma, and in light 
of its prognostic value and relative simplicity and reproducibility, 
a two-tiered grading system for colorectal carcinoma has been 
recommended: low-grade carcinoma (gland formation greater than 
or equal to 50%) and high-grade carcinoma (gland formation less 
than 50%) [72]. The histological grade is assigned according to 
the least-differentiated area found, even though this may appear to 
be quantitatively insignificant [8]. Tumor grade is classified as a 
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favorable grade (low-grade adenocarcinoma) or an unfavorable 
grade (high-grade adenocarcinoma) [68]. 
MARGINS 
The margin of resection, or transection point, is defined as 
the actual free edge of the submucosal connective tissue that 
contains diathermy change [9]. A tumor at the margin is defined as 
cancer cells extending up to the actual transected soft tissue 
margin. A tumor near the margin is defined as cancer cells less 
than or equal to 1 mm from the transected margins, cancer within 
the diathermy change, or within one high-power field of the 
cautery effect [9]. The presence of a tumor at or near the resection 
margin has the same clinical significance and is associated with 
intramural recurrence after local excision an adverse outcome [9], 
even in the absence of any other unfavorable parameters [8]. 
LYMPHATIC INVASION 
The diagnosis of lymphatic invasion requires the presence of 
cancer cells within endothelium-lined channels [9] (Fig. 2.10). 
Lymphatic invasion may be confused with retraction artifact. 
These are most commonly encountered within the invasive tumor 
itself, rather than in the submucosa away from and surrounding the 
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actual invasive cancer [73]. The retraction artifact is often seen 
around small clusters of tumor cells, where reactive fibroblasts 
often surround tumor cells and mimic endothelium-lined channels. 
 
 
Malignant polyps; a, with cancer at the resection margin, 
arrows indicate resection margin; b, with cancer near (1 mm) 
the resection margin (diathermy effect is evident on the 
right) 
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When questionable areas for lymphatic invasion are present, 
subsequent serial and deeper sections are recommended [9]. 
Immunohistochemistry studies have not been of great help in 
establishing or excluding lymphatic invasion [9]. 
VENOUS INVASION 
Venous invasion is defined as tumor emboli within 
endothelium-lined channels surrounded by a smooth muscle wall. 
When one suspects venous invasion, multiple serial or deeper 
sections (and possible elastic stains) are quite helpful in deciding 
whether venous invasion is present [9]. 
The degree of lymphovascular invasion has been defined by 
the Japanese Society for Cancer of the Colon and Rectum. 
Lymphatic (ly) or vascular (v) invasion may be absent (ly0, v0), 
slight (ly1, v1), moderate (ly2, v2), or massive (ly3, v3) [62]. 
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Lymphatic invasion encountered in the submucosa (a, 
magnification 20×; b, magnification 30×) 
TUMOR BUDDING 
Tumor budding, also known as dedifferentiation, is a 
recently recognized feature that represents a highgrade, 
undifferentiated component of a tumor at the leading invasive 
edge [74] (Fig. 2.11). It is defined as an isolated single cancer cell 
or a cluster composed of fewer than five cancer cells observed in 
the stroma of an invasive frontal region [75]. A budding count 
must be done after choosing one field where budding is the most 
intensive. in a field measuring 0.785 mm2, using a 20× objective 
lens [69]. A field with fewer than five budding foci is viewed as 
negative [76]; one with five or more buds is viewed as positive 
[68]. 
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Nonetheless, the intensity of tumor budding also seems to be 
important [77]. Recent evidence suggests that tumor budding is 
associated with both lymphatic invasion and nodal metastases 
[75,78,79]. A number of 0 to 9 foci are classified as a low-grade 
or low- “intensity” tumor budding, while 10 or more buds are a 
high-grade or high-“intensity” tumor budding [79]. Higher 
intensity of tumor budding is significantly associated with higher 
risk of postoperative recurrence [80]. The disease-free survival 
and the overall survival rates dramatically decrease in patients 
with an intensity greater than nine tumor buds [80]. Intensity 
greater than nine may be considered to be an adverse prognostic 
indicator in patients with colon carcinoma [80]. 
Because cell clusters (buds) at the leading invasive edge 
may be quite small and do not form glands or produce mucin, 
identification on histopathological examination may be difficult 
[74] (Fig. 2.12a). A pancytokeratin immunostain may be helpful in 
their identification, especially if accompanied by an inflammatory 
reaction that obscures their presence on hematoxylin- eosin stain 
[74,80] (Fig. 12b). 
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Results indicate that tumour budding is a useful risk factor 
for predicting lymph node metastases in cases of early colorectal 
cancer [81]. 
 
Early colorectal cancer with high degree of tumor budding: 
isolated single cancer cell or a cluster composed of  fewer 
than five cancer cells is defined as a budding focus. Arrows, 
budding foci 
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Colorectal cancer. a, early colorectal cancer with low degree 
of tumor budding. The identification of budding foci is 
difficult because the buds are obscured by inflammatory 
reaction (magnification 12×); b, tumor budding highlighted 
by immunohistochemistry: by using a pan-cytokeratin 
antibody, budding is easily seen (magnification 20×) 
ADENOCARCINOMA IN THE SUBMUCOSA 
(MICROSTAGING)  
If invasive cancer is present, it should be reported the 
amount of adenocarcinomatous component in terms of the volume 
of adenoma replaced by the carcinoma, the depth of its invasion, 
and the width of horizontal spread in the submucosa. This process 
can be called microstaging, and allows the ability to report both 
the level and the extent of the infiltration into the submucosal 
layer. 
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VOLUME OF ADENOMA REPLACED BY THE 
CARCINOMA 
The volume of adenoma replaced by the carcinoma can be 
measured. This is a quantitative ratio, expressed as a percentage. 
Lesions with small foci of invasive carcinoma have lower 
metastatic capability than polyps that are mostly made of invasive 
carcinoma [82]. 
DEPTH OR LEVEL OF INVASION OF THE SUBMUCOSA 
Different staging of invasion into the submucosa has been 
proposed for pedunculated and sessile polyps. The Haggitt levels 
are used for carcinoma in pedunculated polyps [53], and the 
Kikuchi levels [64] are used for carcinoma in sessile polyps [62]. 
The level of invasion in a pedunculated malignant polyp is 
defined within four levels: 
• Level I: invasion is limited to the head of the polyp 
• Level II: invasion into the junction of head and stalk 
• Level III: invasion into the stalk. 
• Level IV: invasion in the submucosa below the stalk. 
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The level of submucosal (sm) invasion in sessile malignant 
polyp is defined within three levels: 
• Sm1: slight submucosal invasion from the muscularis mucosae 
to the depth of 200–300 μm 
• Sm2: intermediate invasion. 
• Sm3: carcinoma invasion near the inner surface of the 
muscularis propria. 
Considering polyp morphology, the sessile type is associated 
with a unfavorable outcome as compared with that of 
pedunculated type. Although patients with sessile polyps 
frequently underwent surgery (85%) [83], their overall mortality 
remained roughly eight times higher when compared with patients 
with pedunculated polyps. This seems to be mainly due to a 
significantly higher prevalence of all the histological risk factors 
in this group rather than to a predetermined biologically 
aggressive behaviour [84,85]. In detail, a positive resection 
margin seemed to be by far the most crucial risk factor in sessile 
polyps, probably because of an inadequate endoscopic removal of 
these lesions. 
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This confirms the previous analysis by Haggitt et al [53], in 
which the level of invasion, but not the sessile morphology, 
seemed to be an independent risk factor for an adverse outcome 
[83]. 
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Haggitt’s levels. Modified from [53], with permission from 
Elsevier 
 
Pedunculated early colorectal cancer: Haggitt’s level I with 
invasion limited to the head of the polyp 
 
Early colorectal cancer: Haggitt’s level II (invasion to the 
junction of head and stalk). The margin is the cauterized 
submucosa (black star) and not the dangling wings of 
mucosa (arrows) 
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The Haggitt classification is less useful for sessile tumors. 
According to these criteria, invasive cancer arising in a 
pedunculated adenoma could be classified as level I to level IV. 
Invasive cancer arising in a sessile adenoma is, by definition, a 
level IV lesion (Fig. 2.17). In sessile and semi-sessile adenomas 
there will most likely be an invasion into the submucosa of the 
bowel wall, and the patient will therefore be at higher risk for 
metastasis compared to early invasive carcinomas arising in 
pedunculated adenomas [8]. 
MEASURING THE LEVEL OF SUBMUCOSAL INVASION 
Extension into the submucosal layer may be expressed by 
micrometric measurement of depth and width of submucosal 
invasion. It is a numerical measurement regarding depth and width 
of tumor invasion. Depth invasion (vertical distance) is estimated 
from the lower edge of the muscularis mucosae to the deepest 
invasive front. When the muscularis mucosae cannot be identified, 
the vertical distance from apex of the tumor to the deepest 
invasive front is measured. Width invasion measures the greatest 
width of submucosal of invasion [68]. 
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Kikuchi’s levels. Modified from [63] 
 
Sessile early colorectal cancer: Haggitt’s level IV; Kikuchi’s 
level sm1 with invasion from the muscularis mucosae 
measuring less than 300 μm deep 
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Numerical data regarding the extent of submucosal invasion 
aids in identifying tumors with very little risk for nodal 
involvement in patients with an absence of unfavorable parameters 
[68]. Width of submucosal invasion less than 4 mm, and depth of 
submucosal invasion less than 2 mm, in the absence of 
unfavorable parameters, identify tumors with very little risk for 
nodal involvement, and metastatic capability close to zero per cent 
[68]. Moreover, by estimating the extent of submucosal invasion, 
it is possible to identify within the low-risk early colorectal 
cancer, a subgroup of lesions with virtually no risk of nodal 
metastasis: depth of submucosal invasion less than0.3 mm (sm1), 
or depth of submucosal invasion less than 2 mm joined at a width 
of submucosal invasion less than 4 mm with negative budding 
[54,68]. 
These pathological parameters define two groups of early 
colorectal cancer with different risk of nodal and/or local 
recurrence: low- and high-risk early colorectal cancer. A low-risk 
early colorectal cancer is defined as being a completely excised 
Haggitt level 1 to 3 or Kikuchi Sm1 and possibly Sm2 depth of 
invasion, with no evidence of poorly differentiated 
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adenocarcinoma or lymphatic or vascular invasion [62] and low-
grade tumor budding [54,80]. It is now generally accepted that 
local excision, by either endoscopic polypectomy or transanal 
surgery, is adequate treatment for a low-risk early colorectal 
cancer [62]. A high-risk early colorectal cancer is defined as one 
that has one or more of the following characteristics: a positive 
resection margin, a high tumor grade, an Sm3 or possibly an Sm2 
depth of invasion, presence of lymphatic or vascular invasion, or a 
high grade of tumor budding [54,62,80]. 
Low- and high-risk early colorectal cancers differ, not only 
with regard to lymph node metastases, but also to distant 
metastasis and mortality rates [71]. Such adverse clinical 
outcomes occur despite the majority of high-risk patients 
undergoing surgical resection. This observation strengthens the 
usefulness of this classification not only for addressing the 
therapeutic choice, but also as a staging procedure. 
49 
 
Width and depth of submucosal invasion. Modified from 
[68] with permission from Elsevier 
 
REPORTING MALIGNANT POLYPS GROSS FEATURES 
• Macroscopic growth pattern: pedunculated/sessile/ flat polyp. 
• Greatest dimension. 
HISTOLOGICAL FEATURES 
• Grade of adenocarcinoma: low-grade/high-grade dysplasia. 
• Status of the resection margin. 
• Presence or absence of lymphatic or venous invasion. 
• Tumoral budding. 
• Microstaging:  
o volume of adenoma replaced by the carcinoma; 
o levels of invasion of the submucosa: 
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o Haggitt’s levels (pedunculated polyp) 
o Kikuchi’s classification (sessile polyp) 
o depth and width of infiltration of the submucosa. 
PSEUDOCARCINOMATOUS ENTRAPMENT 
(PSEUDOINVASION) 
A recognized histological pitfall in diagnosing adenoma is 
the presence of “entrapped” (pseudoinvasive) dysplastic glands in 
the submucosa mimicking invasive adenocarcinoma. 
Pseudocarcinomatous entrapment, variously termed colitis cystica 
profunda, submucosal cysts, pseudocarcinomatous invasion, or 
epithelial misplacement, affects a small proportion of pedunculated 
adenomas usually located in the sigmoid colon (64% to 85%) [8]. 
Repeated episodes of torsion lead to hemorrhage, inflammation, 
and ulceration of the adenoma. As a result, the adenomatous glands 
herniate through the muscularis mucosae into the underlying 
submucosa. Forceps biopsies may also cause epithelial displacement: 
the adenomatous tissue may be pulled further into the stalk by 
contraction of fibrous tissue as the biopsy site heals [86]. 
Histologically, areas of pseudoinvasion can be recognized 
by the presence of adenomatous glands in a submucosa without 
cytological evidence of malignancy. Pseudoinvasion is 
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characterized by the presence of entrapped adenomatous glands in 
a submucosa surrounded by normal lamina propria with 
hemosiderin deposits, as opposed to a desmoplastic response in 
invasive carcinoma. The degree of dysplasia in the displaced 
glands often resembles that of the glands immediately overlying it, 
and the displaced glands may also coexist with non-neoplastic 
glands that were displaced along with the neoplastic ones. 
 
Adenoma with pseudocarcinomatous entrapment: at high 
magnification the displaced pseudoinvasive glands 
demonstrated low-grade dysplasia and are surrounded by 
lamina propria. Siderogenous desmoplasia is present within 
the submucosa (brownish color comes from the presence of 
hemosiderinladen macrophages) 
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GROSS EXAMINATION AND CUTTING OF POLYPS 
Fixation 
Adenomas should be fixed prior to cutting. The polyp should 
be placed in an adequate volume of fixative (at least ten times the 
volume of the tissue). The length of time needed for adequate 
fixation varies with the size of the polyp (i.e. larger polyps need 
longer fixation). The pathologist can often appreciate when the 
tissue is adequately fixed and firm enough for subsequent 
sectioning, by careful palpation of the polyp [9]. 
Ideally, the endoscopist should indicate the stalk of larger 
adenomas by placing a needle at its base when the polyp is 
removed from the endoscope. Realistically,this almost never 
happens. Occasionally, the pathologist and the endoscopist 
disagree as to whether a stalk is present or how long the stalk is, 
since the stalk often retracts into the head of the adenoma. 
Occasionally, the precise orientation of the polyp cannot be 
identified clearly; sectioning at several levels may then be needed 
to recognize the exact anatomical relationships. However, some 
specimens defy accurate orientation so that the assessment of 
margins may be impossible. In this case, the margins are reported 
as not evaluable. 
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Sampling 
Once fixed, the entire lesion should be examined 
histologically. When one receives polyp biopsies or polypectomy 
specimens, it is important to record all of the pathological 
features, including the number of tissue fragments received, their 
size, their gross morphology (i.e. pedunculated or sessile), and 
their locations. The stalk of a pedunculated polyp or the point of 
transection of sessile or semipedunculated polyps should be 
identified. In sessile and semipedunculated polyps, the point of 
transection can often be identified as an ashen white area of 
discoloration. It is possible to identify the excision edge of the 
specimen due to the presence of a prominent cautery effect [62]. 
The endoscopist should identify the point of transaction with 
India ink; a pin is another method of identifying the point of 
transection in sessile polyps [9]. Polyps should be cut in the 
sagittal plane through the stalk or the point of transection, such 
that all the relevant microscopic landmarks will be easily 
assessable. If piecemeal polypectomy is unavoidable, the 
endoscopist can place the true transected margin in a separately 
identified container, or use a pin or India ink to identify the true 
margin of transection. It is also important that the endoscopist 
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informs the pathologist whether the polypectomy was believed to 
be complete or incomplete [9]. 
Tissue fixation ensures retention of the ball shape, making 
identification of the resection site difficult. This artifact can be 
avoided by having the endoscopist place sessile polyps on a firm 
matrix, such as a piece of paper or Gelfoam, before placing the 
specimen in the fixative. 
If the lesion is pedunculated and received in a fresh state, it 
can be fixed in such a way that the stalk is pinned to a piece of 
cork. The histological classification of fractional biopsies of 
smaller adenomas (<1.7 cm) are in 88.9% agreement with the final 
diagnosis in the polypectomy specimen, whereas the reliability of 
the biopsies in accurately diagnosing adenomas >1.7 cm is only 
27.68%. Invasive carcinomas are frequently missed in biopsies 
taken of larger lesions [8]. 
This diagnosis is made on either a polypectomy specimen or 
a biopsy of sessile lesions. Diagnosing areas of invasive 
carcinoma on a midsagittal section of a pedunculated adenoma is 
often easier than making a diagnosis of invasion on a small 
forceps biopsy of a larger lesion. Biopsy fragments in which the 
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neoplastic cells mingle with the fat, medium-sized blood vessels, 
nerve trunks, ganglia, or large lymphatics can be diagnosed as 
invasive lesions. 
PATHOLOGY OF POST-POLYPECTOMY RESECTION 
SPECIMENS 
The reports from pathologists with regard to the 
postpolypectomy resection specimens have to focus on two 
significant statements: (1) the presence of residual neoplastic cells 
at the site of previous polypectomy, and (2) the presence of 
lymph-nodal metastases. On gross examination of the resection 
specimens, it is important to identify the actual polypectomy site. 
If the resection is performed within approximately 10 days post-
polypectomy, the polypectomy site will usually be apparent as an 
area of erosion, ulcer, or induration. When resections are 
performed more than 10 days post-polypectomy, it is often 
difficult to identify the polypectomy site, which has probably 
healed and re-epithelialized. 
In a fresh unfixed specimen, if the polypectomy site is not 
grossly obvious, the pathologist, by careful palpation, can often 
find an area of induration that corresponds to the polypectomy 
site. The polypectomy site should be confirmed microscopically. 
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In instances of delayed resection with re-epithelialization of the 
polypectomy site, one should look for focal fibrosis, thrombosed 
submucosal blood vessels, occasional giant cells, disruption of the 
muscularis mucosae, etc, to confirm the polypectomy site. If, after 
taking the routine number of sections, one is unsuccessful in 
finding the polypectomy site, more random sections should be 
taken. No specific number is recommended, but the sampling 
should be extensive. If, after extensive sampling, the site is not 
found, the pathology report should clearly indicate that the 
polypectomy site was not found. This should indicate to the 
surgeon that there is a possibility that the correct area of bowel 
may not have been removed. To facilitate finding the polypectomy 
site, the endoscopist might tattoo the area with India ink. This 
tattoo remains for several months [9]. 
With respect to lymph nodes, it should be remembered that 
all nodes present must be sampled. It has been shown that a 
minimum of 12 to 18 lymph nodes must be examined to accurately 
predict regional node negativity in colorectal cancer [87–90]; 
moreover it has been suggested that 12 lymph nodes be considered 
the minimum number that is acceptable [72,88]. 
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MATERIALS AND METHODS 
The centre of study was Department of Medical 
Gastroenterology, Madras Medical College and Rajiv Gandhi 
Government General Hospital, Chennai-3. 
STUDY DESIGN 
Prospective 
VENUE 
Rajiv Gandhi Government General Hospital, Chennai-3. 
DURATION OF STUDY 
December 2008 to January 2011. 
COLLABORATING DEPARTMENT 
Department of Pathology, Madras Medical College, 
Chennai-600 003. 
METHODOLOGY 
Patients who are attending department of Medical 
Gastroenterology and those patients referred from other medical 
and surgical wards. Patients suspicious of gastroenterology polyps 
or with family history of polyps. 
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PATIENT SELECTION 
Inclusion Criteria 
Patients with family history of GI polyps and those found to 
have GI polyps on routine endoscopy. 
Exclusion Criteria 
1) Patients not willing for consent 
2) Patients with serious cardiac and respiratory disorders 
3) Pregnant women 
4) Respiratory failure 
5) Renal failure 
6) Psychiatric diseases  
PROTOCOL  
1) All the patients who met the above criteria were included in 
the study and got admitted in our department. 
2) The following were noted in each patient. 
a. Age 
b. Sex 
c. Educational Status 
d. Symptoms of patients suspicious of GI polyps 
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3) Data collection methods 
a. Detailed clinical history 
b. Hemogram 
c. Upper and lower GI endoscopy as applicable 
d. Biopsy of the lesion 
e. Biopsy of the specimen to be sent for histopathologic 
examination. 
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RESULTS 
Total number of patients – 50 
Total number of male patients – 33 
Total number of female patients – 17 
Male : Female ratio – 2:1 
AGE 
Mean age 
Male patients – 55.6 years 
Female patients – 49.1 years 
UPPER GI FINDINGS 
Esophageal polyps – 4 (8%) 
Gastric polyps – 14 (28%) 
Duodenal polyps – 4 (8%) 
Colonic polyps – 28 (56%) 
CLINICAL PRESENTATION 
Esophageal polyps presented with dysphagia-1, 
Odynophagia-1, Hold up -2. 
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GASTRIC POLYPS 
7 patients (50%) presented with non specific symptoms like 
pain abdomen. 4 patients presented with features of dyspepsia like 
belching, abdominal bloat. Two patients presented with upper GI 
bleed. One hematemesis and one patient with melena. 
DUODENAL POLYPS 
Of the four patients who presented with duodenal polyps one 
patient presented with vomiting, one patient presented with chronic 
diarrhea, two patients presented with vague abdominal pain. 
COLONIC POLYPS 
26 patents presented with bleeding per rectum (95%).  
2 patients presented with blood and mucous diarrhea and 
altered bowel habits. 
TYPES OF POLYPS 
Sessile polyps  : 25 (50%) 
Pedunculated polyps : 8 (10%) 
Polypoidal mass : 16 (32%) 
Pseudo polyp : 1 (2%) 
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HISTOPATHOLOGY  
Inflammatory polyps : 11 (22%) 
Hyperplastic polyps : 18 (36%) 
Tubular Adenoma : 8 (16%) 
Villous Adenoma : 2 (4%) 
Tubulo Villous : 5 (10%) 
Adeno carcinoma (Gastric) : 1 (2%) 
Adeno carcinoma (Colonic) : 2 (4%) 
Lympho proliferative disorder : 1 (2%) 
Fibro epithelial polyp : 1 (2%) 
Peutz Jeghers Polyps : 1 (2%) 
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DISCUSSION 
Of all the gastro intestinal polyps in our study colonic 
polyps was predominant – 28 patients (56%). 
Symptom wise 
Bleeding per rectum : 14 
Altered bowel habits : 4   
Pain during defecation : 4 
Chronic diarrhea : 2 
Perianal fistula with serous discharge : 1 
One patient had been operated for  
growth rectum 4 months earlier : 1 
Iron deficiency anemia : 1 
Perioral pigmentation S/o  
Peutz Jeghers  : 1 
From the above analysis it is clear that bleeding/ rectum and 
altered bowel habits were the presenting symptoms in majority of 
patients with colorectal polyps (64%) which is in contrast to a 
study on colorectal polyps where only 6.04% patients presented 
with bleeding per rectum, pus discharge and perianal pain.  
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Ref: A study on gastrointestinal polys- Clinico pathological 
aspects: Esmaily HA, Mostafapour E, Research Journal of 
Biological Sciences – 57-63-2008. 
COLONIC POLYPS- HISTOPATHOLOGY 
Tubular adenoma : 5 
Tubulo villous adenoma : 5 
Villous adenoma : 3 
Hyperplastic polyps : 10 
Adeno carcinoma : 3 
Peutz – Jeghers Polyp : 1 
Pseudo Polyp : 1 
It is clear from the above data that hyperplastic polyps are 
the most common (35%) histologic type. This is in contrast to a 
study by  
Esmaeily HA, Mostafapour E: Gastro intestinal polyps- 
Clinicopatholoigcal aspects- Research Journal of Biological 
Sciences, 57-63, 2008. 
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Where tubularadenoma was the frequent subtype 
constituting 71% of all adenomatous polyps. 
One patient who had perioral pigmentation and suspected of 
having Peutz Jeghers syndrome was evaluated. When the patient 
was undergoing CT enteroclysis developed signs of intestinal 
obstruction. Patient was operated and two polyps retrieved from 
jejunum. Histopathology of the polyps showed features of Peutz 
Jegher’s Polyp.  
One patient who presented with blood and mucous diarrhea 
showed endoscopic features of inflammatory bowel disease and 
histopathology showed inflammatory pseudopolyp. 2 patients had 
histopathologic features of adenocarcinoma. 
Sigmoid Polyp 
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Rectum Recto- Sigmoid 
  
Snare Around Polyp Stalk of the polyp 
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Retrieved Polyp  
 
 
HISTOPATHOLOGY OF POLYPS 
 
Pedunculated polyp  
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Sessile polyp  
 
Flat adenoma 
 
Villous adenoma  
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Tubulo-villous adenoma 
 
High-grade dysplasia 
ESOPHAGEAL POLYPS  
Esophageal polyps in this study showed histopathologic 
features showed histopathologic features of hyperplastic polyps – 
2 (50%), Inflammatory polyps-1. 
This is similar to a study on hyperplastic polyps of the 
esophagus and esophago gastric junction.  
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Histologic and clinico pathologic findings. 
Abraham SC, Yardley JH, Johns Hokins University school 
of Medicine, Baltimore. 
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GASTRIC POLYPS 
Gastric polyps in our study presented with the following 
symptoms 
 Hemetesis- 1 
 Melena-1 
 Dyspeptic symptoms-6 
 Vomiting-3 
 Anaemia for evaluation- 2 
 Asymptomatic -1 
As for the location of gastric polyps only 2 patients showed 
fundic polyps, antral polyps were 5, polyps in pyloric region 4, 
polyps involving body 1, 2 patients showed polyps scattered 
throughout the stomach. 
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The histopathology of one patient with antral polyp turned 
out to be adenocarcinoma. Fundic gland polyps were 
inflammatory polyps (3). Rest of the gastric polyps were 
hyperplastic (3). adenomatous polyps (2). 
GASTRIC POLYPS (CARDIA) 
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DUODENAL POLYPS  
In the duodenal polyps in our study one turned out be a 
lympho proliferative disorder (IPSID) confirmed with immuno 
histochemistry. Three others showed non specific inflammation 
(75%). 
In a study by 
Remmelew Hartmannw, Vonder Ladden on duodenal polyps 
reported in histopathology of duodenal polyps in pubmed” 
Hyperplastic polyps were most common (68%). 
Another Study,  
Prospective study of prevalence endoscopic and 
histopathologic characteristics of duodenal polyps in patients 
submitted to endoscopy 
74 
Jepsen JM, Person M, Jakobsen O, Institute of Pathology/ 
University of Arthus, Denmark, Scand J of GE 1994, 29: 483. 
Histopathology of duodenal polyps is inconsistent. In the 
descending duodenum polyps are rare but significant number of 
them are adenomas. Biopsy is therefore mandatory in this 
localization. 
75 
CONCLUSION 
This study has highlighted the importance of screening for 
patients with upper Gastro Intestinal Symptoms by detection of 
unsuspected polyps (44% upper GI polyps). Regarding lower 
gastrointestinal polyps colonoscopic screening has helped to 
detect polyps and the histopathological types has helped us in 
offering proper management options like polypectomy is many. In 
two patients which appeared as non malignant histopathological 
examination detected malignancy in them and further 
investigations helped us to offer curative resections for these 
patients. 
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 MASTER CHART 
S.No Name Age Sex Clinical Features Endoscopic Findings Histopathology 
1.  Chinnaponnu 45 F Asymptomatic Upper GI endoscopy: 
Sessile polyp in the antrum 
nodular thickened mucosa 
Infiltrating adenocarcinoma- 
Poorly differentiated  
2.  Latha 42 F Vague abdomen pain 
vomiting on and off 
Bx from sessible polyp in 
the bulb 
Superficial ulceration of mucosa 
with inflammation cell infiltration 
of lamina propria 
3.  Muthalagan 60 M Occassional hold up 
of solids 
Bx from small polyp above 
OGJ 
Shows a tiny polypoidal tissue 
covered by columnar epithelium 
with goblet cells inflammatory 
cells in the stroma. Imp: 
Inflammatory polyp 
4.  Anthonysmay 58 M Bleeding perrectum Colonoscopy findings. A 
small sessile polyp at 60 
cms 
Shows tubules and glands of 
varying sizes lined by single layer 
of columnar epithelium. Imp: 
Tubular adenoma, No c/o 
dysplasia 
5.  Anantah 
Sayanam 
40 M Bleeding per rectum 
altered bowel habits 
Colonoscopy findings 
polyps of varying sizes 
from mucosa of rectum 
both sessile and 
pedunculated polyps 
Shows mucosa of surface lined by 
several villous process lined by 
single layer of columnar cells 
shows some tubular glands in the 
mucosa and submucosa. 
Imp:Tubulovillous adenoma 
 S.No Name Age Sex Clinical Features Endoscopic Findings Histopathology 
6.  Sivasamy 60 M Bleeding per rectum Sessible polyp seen in 
rectum (Bx taken) 
Shows a polypoidal mass 
composed of tubular glands of 
varying sizes lined by single layer 
of columnar epithelium with few 
papillary process 
7.  Munawar 
Ahamed 
20 M Chronic diarrhea Bx from polypidal lesion 
in D2. 
? Lymphoma, ? 
Lymphangiectasia 
Shows flo lymphoproliferative. 
To confirm with IHC markers 
8.  Subramani 59 M Vague abdomen 
discomfort 
Bx from polypoidal lesion 
in bulb 
Shows superficial ulceration of 
duodenal mucosa with 
lymphocytic and on sunplulic 
infiltration no e/o malignancy 
9.  Veerammal 37 F Altered bowel habits Colonoscopy: 
Pedunculated polyp seen at 
proximal transverse colon 
(Bx taken) 
Features S/o infiltrating 
adenocarcinoma 
10.  Jayaseeli 60 F Vague abdomen 
discomfort 
OGD: Polypoid lesion seen 
at prepyloric region 
Shows hyperplastic polyp with 
C/o. congestion and mild 
inflammation 
11.  Ranganathan 71 M Bleeding per rectum Colonoscopy: Sessile 
polyp in rectum. Multiple 
diverticulae in cecum and 
ascending colon 
Shows fragments of hyperplastic 
colonic mucosa with one showing 
F/o. tubular adenoma and villous 
process. Imp: Tubulo villous 
adenoma. 
 S.No Name Age Sex Clinical Features Endoscopic Findings Histopathology 
12.  Kuttiammal 62 F Pain abdomen passes 
black tarry stools 
OGD: multiple polyps in 
stomach involving body 
lesser and grater curve (Bx 
taken) 
Shows fragments of hyperplastic 
gastric mucosa with superficial 
ulceration nnappanand 
inflammatory cell infiltration. 
Imp: Hyperplastic polyp with 
ulceration. 
13.  Chinnappan 73 M Vague abdomen 
discomfort 
Sessile polyp in distal 
antrum 
Hyperplastic polip 
14.  Marimuthu 70 M Pain during 
defecation occasional 
bleeding PR 
Coloscopy: passed upto 
50cm from analverge small 
pedunculated polyp at 
18cm (Bx A) multiple 
small sessile polyps seen 
between 7-12cms from 
anal verge (Bx) 
Both biopsy fragments showed 
features of hyperplastic polyp 
15.  Balakrishnan 48 M Pain abdomen and one 
episode of 
hematemesis 
OGD: Multiple small 
polyps scattered 
throughout the stomach 
Shows fragments of hyperplastic 
polyps 
16.  Jayanhthi 22 F Bleeding per rectum Colonoscopy: Multiple 
polyps involving entire 
colon 
Villous adenoma with low grade 
dysplasia 
17.  Shankar 61 M Pain during 
defecation 
Anorectal polypectomy 
specimen 
Section shows polypoid lesion 
showing surface and necrotic acute 
inflammatory granulation tissue. 
IHC:CD34-Neg, CD 20-Positive 
 S.No Name Age Sex Clinical Features Endoscopic Findings Histopathology 
18.  Ragupathy 74 M Pain during 
defecation 
Colonoscopy: Sessile 
polyp seen just beyond 
anal verge and normal 
overlying mucosa 
Chronic inflammatory polyp 
19.  Shanmugam 59 M Altered bowel habits Colonoscopy: Passed upto 
5cm of terminal ileum tiny 
polyp seen at cecum 
Colonic mucosal glands with 
predominantly normal mucin with 
some glands showing low grade 
dyslasia. Imp:Adenoma 
20.  Chandra 55 F Dyspeptic Symptoms Sessile polyp in fundus Non specific inflammation 
21.  Doss 44 M Altered bowel habits 
with occasional  
bleeding per rectum 
Colonoscopy: 
Pedunculated polyp 
visualized in mid 
descending colon 
Features S/o. adenocarcinoma 
22.  Yuvarani 33 F Pain abdomen and 
dyspepsia 
Tiny polyp in the proximal 
antrum 
Non specific inflammatory polyp 
23.  Suseela 63 F Bleeding per rectum Colonoscopy: 
Pedunculated polyp with 
2cm stalk seen at mid 
descending colon 
Adenomatous polyp 
24.  Varatharajan 75 M Pain abdomen with 
occasional vomiting 
Pedunculated polyp seen at 
pylorus with a short pedicle 
Hyperplastic polyp 
 S.No Name Age Sex Clinical Features Endoscopic Findings Histopathology 
25.  Govindammal 40 F Dyspeptic symptoms 
otherwise 
asymptomatic 
Small sessile polyp seen at 
the junction of body and 
antrum 
Adenomatous polyp with foci 
shows mild atypia 
26.  Ekambaram 55 M Bleeding per rectum Colonoscopy: Single 
pedunculated polyp in 
sigmoid colon. 
Polypectomy done 
Features of tubular adenoma 
adjacent mucosa shows 
inflammation and mild polypoidal 
hyperplasia 
27.  Bhuvaneswari 25 F Blood and mucous 
diarrhoea 
Colonoscopy: Colonic 
mucosa inflamed with 
ulceration and loss of 
vascular pattern multiple 
polyps of varying seen 
50cm from anal verge 
Markedly inflamed colonic 
mucosa with features of 
ulcerative colitis and hyperplastic 
pseudopolyp 
28.  Jeeva 60 F Pain abdomen and 
dyspepsia 
Bx taken from Gastric 
antrum 
Fragments of polypoidal mucosa 
with benign cytology 
29.  Ramasamy 48 M Chronic diarrhea and 
occasional bleeding 
per rectum 
Colonoscopy: Scope 
passed upto cecum Bx 
taken from sessile polyp in 
ascending colon 
Features of tubular adenoma 
30.  Periyanayaki 70 F Late onset dyspepsia OGD: Multiple polyps in 
antrum, fundus and leser curve 
Hyperplastic polyp with C/o mild 
and inflammation 
31.  Gnanprakasam 58 M Perianal fistula and 
serous discharge 
Colonoscopy: Rt. Small 
sessile polyps of size 4mm 
another polyp 2mm seen 
35cm from anal verge 
Features of tubular adenoma 
 S.No Name Age Sex Clinical Features Endoscopic Findings Histopathology 
32.  Kalidoss 50 M Vague abdomen 
discomfort and looze 
stools 2 months 
2 sessile polyps in cecum Hyperplastic polyp 
33.  Govindasamy 70 M Growth rectum (low 
anterior resection 
done) 
Colonoscopy: Small sessile 
polyp 25cm from anal 
verge 
Features of hyperplastic polyp 
34.  Sukumaran 62 M Altered bowel habits/ 
constipation 
alternating with 
diarrhea 
Colonoscopy: Polyp in 
ascending colon 
Hyperplastic polyp 
35.  Pattu 70 F Peptic ulcer like 
symptomus 
Sessile polyp in 1st part of  
duodenum 
Hyperplastic polyp 
36.  Durairaj 63 M Occassional hold up Small esophageal polyp 
27cm from the incisor 
teeth 
Hyperplastic squamous 
epithelium without e/o 
malignancy 
37.  Pandiyan 61 M Chronic constipation Colonoscopy: A small 
polyp seen at splenic 
flexure 
Shows small polypoidal mass 
composed of glands lined by 
mucous epithelium. Imp: 
Hyperplaatic polyp 
38.  Sankaran 56 M Bleeding per rectum 2 sessile polyps seen at 
10cm from anal verge 
Shows strips of rectal mucosa 
with c/o non specific 
inflammation 
39.  Angaiah 68 M Odynophagia and 
holdup 
Polyp at OGJ Hyperplastic polyp 
40.  Sundaram 62 M Iron deficiency 
anemia 
Colonoscopy: Small sessile 
polyp in ascending colon 
Hyperplastic polyp 
 S.No Name Age Sex Clinical Features Endoscopic Findings Histopathology 
41.  Moorthy 54 M Blood and mucous 
diarrohea 
Pedunculated polyp in 
sigmoid colon (Bx taken) 
Section shows fragments of 
polypoidal mass containing 
tubular glands with one focus 
showing small villous process 
with mild dysplastic changes. 
Imp: Tubulo villous adenoma 
with dysplastic change 
42.  Mallika 47 F Occassional vomiting Bx from polyp in the 
pyloric ring 
Hyperplastic polyp 
43.  Dasarathan 66 M Bleeding per rectum Colonoscopy: 2 polyps 
sessile and pedunculated 
seen in rectum and about 
18cm from anal verge 
Tubulo adenomatous changes 
seen 
44.   50 F Pain and bleeding 
during defecation 
Colonoscopy: Sessile 
polyp seen in rectum 
Hyperplastic polyp 
45.  Eswaran 30 M Blood and mucous 
stools 
Multiple polyps throughout 
the colon ?FAP 
Section shows a polyp compsed 
of glands arranged in tubular 
pattern, and in villous patter lined 
by columnar epithelial cells 
having uniform bowel muclei. 
Imp: Tubulovillous adenoma 
 
46.  Murugan 20 M Peroral pigmentation 
of palms suspected 
Peutz Jeghers 
syndrome 
Rectal polyp Adenomatous polyp 
 S.No Name Age Sex Clinical Features Endoscopic Findings Histopathology 
47.  Shankar 35 M Patient presented with 
features of intestinal 
obstruction. Patient 
also had perioral 
pigmentation 
Surgically removed polyp 
from jejunum  
Peutz jeghers polyp 
48.  Selvam 40 M Patient presented with 
dysphagia 
3mm sessile polyp at 32 
cm from incisor teeth 
(esophageal polyp) 
Fibro epithelial polyp 
49.  Shanmugam 65 M Bleeding for rectum Colonoscopy: Scope 
passed upto spelenic 
flexure 5mm polyp in recto 
sigmoid 
Shows small polypoidal mass 
composed of tubular glands lined 
by columnar epithelial cells. Imp: 
Tubular adenoma 
50.  Vanitha 45 F Anaemia for 
evaluation 
OGD: Large polypoidal 
lesion in the prepyloric 
region abutting the pyloric 
opening 
Shows fragments of antral 
mucosa with hyperplastic glands 
and non specific inflammation. 
Imp: Hyperplastic polyp. 
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4) I have been explained about my rights and responsibilities by the 
investigator. 
5) I have been adviced about the risk associated with my 
participation in this study. 
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information obtained from me as a result of participation in this 
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